Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Non Operating Investment Income (2016 - 2022)

Marimed has reported Non Operating Investment Income over the past 7 years, most recently at $48000.0 for Q1 2022.

  • Quarterly Non Operating Investment Income rose 206.67% to $48000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Mar 2022, down 446.63% year-over-year, with the annual reading at -$1.1 million for FY2021, 216.5% down from the prior year.
  • Non Operating Investment Income was $48000.0 for Q1 2022 at Marimed, up from -$169203.0 in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at $354534.0 in Q4 2020 and troughed at -$687002.0 in Q1 2020.
  • The 3-year median for Non Operating Investment Income is -$169203.0 (2021), against an average of -$156451.8.
  • Year-over-year, Non Operating Investment Income tumbled 340.19% in 2021 and then skyrocketed 206.67% in 2022.
  • A 3-year view of Non Operating Investment Income shows it stood at $354534.0 in 2020, then plummeted by 147.73% to -$169203.0 in 2021, then skyrocketed by 128.37% to $48000.0 in 2022.
  • Per Business Quant, the three most recent readings for MRMD's Non Operating Investment Income are $48000.0 (Q1 2022), -$169203.0 (Q4 2021), and -$522106.0 (Q3 2021).